My NCBISign In

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination
  • Your browser version may not work well with NCBI's Web applications. More information here...

Results: 1 to 20 of 324

1.

Effects of statins on the secretion of human serum albumin in cultured HepG2 cells.

Ha CE, Ha JS, Theriault AG, Bhagavan NV.

J Biomed Sci. 2009 Mar 16;16:32.PMID: 19291315 [PubMed - indexed for MEDLINE]Related articlesFree article

2.

Differential efficacy of 3-hydroxy-3-methylglutaryl CoA reductase inhibitors on the cell cycle of prostate cancer cells.

Sivaprasad U, Abbas T, Dutta A.

Mol Cancer Ther. 2006 Sep;5(9):2310-6.PMID: 16985065 [PubMed - indexed for MEDLINE]Related articlesFree article

3.

Comparison of the efficacies of five different statins on inhibition of human saphenous vein smooth muscle cell proliferation and invasion.

Turner NA, Midgley L, O'Regan DJ, Porter KE.

J Cardiovasc Pharmacol. 2007 Oct;50(4):458-61.PMID: 18049315 [PubMed - indexed for MEDLINE]Related articles

4.

Distinct effects of pravastatin, atorvastatin, and simvastatin on insulin secretion from a beta-cell line, MIN6 cells.

Ishikawa M, Okajima F, Inoue N, Motomura K, Kato T, Takahashi A, Oikawa S, Yamada N, Shimano H.

J Atheroscler Thromb. 2006 Dec;13(6):329-35.PMID: 17192698 [PubMed - indexed for MEDLINE]Related articlesFree article

5.

HMG CoA reductase inhibitors affect the fibrinolytic system of human vascular cells in vitro: a comparative study using different statins.

Wiesbauer F, Kaun C, Zorn G, Maurer G, Huber K, Wojta J.

Br J Pharmacol. 2002 Jan;135(1):284-92.PMID: 11786505 [PubMed - indexed for MEDLINE]Related articlesFree article

6.

Simvastatin, an HMG-CoA reductase inhibitor, induces the synthesis and secretion of apolipoprotein AI in HepG2 cells and primary hamster hepatocytes.

Bonn V, Cheung RC, Chen B, Taghibiglou C, Van Iderstine SC, Adeli K.

Atherosclerosis. 2002 Jul;163(1):59-68.PMID: 12048122 [PubMed - indexed for MEDLINE]Related articles

7.

Inhibitors of HMG-CoA reductase reduce receptor-mediated endocytosis in human kidney proximal tubular cells.

Verhulst A, D'Haese PC, De Broe ME.

J Am Soc Nephrol. 2004 Sep;15(9):2249-57.PMID: 15339974 [PubMed - indexed for MEDLINE]Related articlesFree article

8.

Brain cholesterol synthesis in mice is affected by high dose of simvastatin but not of pravastatin.

Thelen KM, Rentsch KM, Gutteck U, Heverin M, Olin M, Andersson U, von Eckardstein A, Björkhem I, Lütjohann D.

J Pharmacol Exp Ther. 2006 Mar;316(3):1146-52. Epub 2005 Nov 10.PMID: 16282522 [PubMed - indexed for MEDLINE]Related articlesFree article

9.

Simvastatin impairs mitogen-induced proliferation of malignant B-lymphocytes from humans--in vitro and in vivo studies.

Vitols S, Angelin B, Juliusson G.

Lipids. 1997 Mar;32(3):255-62.PMID: 9076662 [PubMed - indexed for MEDLINE]Related articles

10.

Inhibition of monocyte chemotactic protein-1 synthesis by statins.

Romano M, Diomede L, Sironi M, Massimiliano L, Sottocorno M, Polentarutti N, Guglielmotti A, Albani D, Bruno A, Fruscella P, Salmona M, Vecchi A, Pinza M, Mantovani A.

Lab Invest. 2000 Jul;80(7):1095-100.PMID: 10908155 [PubMed - indexed for MEDLINE]Related articles

11.

HMG-CoA reductase inhibitors induce apoptosis in pericytes.

Boucher K, Siegel CS, Sharma P, Hauschka PV, Solomon KR.

Microvasc Res. 2006 Mar;71(2):91-102. Epub 2006 Jan 19.PMID: 16427097 [PubMed - indexed for MEDLINE]Related articles

12.

Statins inhibit proliferation and induce apoptosis in Barrett's esophageal adenocarcinoma cells.

Ogunwobi OO, Beales IL.

Am J Gastroenterol. 2008 Apr;103(4):825-37. Epub 2008 Mar 24.PMID: 18371146 [PubMed - indexed for MEDLINE]Related articles

13.

Chronic administration of statins alters multiple gene expression patterns in mouse cerebral cortex.

Johnson-Anuna LN, Eckert GP, Keller JH, Igbavboa U, Franke C, Fechner T, Schubert-Zsilavecz M, Karas M, Müller WE, Wood WG.

J Pharmacol Exp Ther. 2005 Feb;312(2):786-93. Epub 2004 Sep 9.PMID: 15358814 [PubMed - indexed for MEDLINE]Related articlesFree article

14.

Targeting low HDL-cholesterol to decrease residual cardiovascular risk in the managed care setting.

Cziraky MJ, Watson KE, Talbert RL.

J Manag Care Pharm. 2008 Oct;14(8 Suppl):S3-28; quiz S30-1. Review.PMID: 19891279 [PubMed - indexed for MEDLINE]Related articles

15.

Inhibitory effect of statins on fetal bovine serum-induced proliferation of rat cultured mesangial cells and correlation between their inhibitory effect and transport characteristics.

Nagasawa K, Muraki Y, Matsuda T, Ohnishi N, Yokoyama T.

J Pharm Sci. 2000 Dec;89(12):1594-604.PMID: 11042608 [PubMed - indexed for MEDLINE]Related articles

16.

[Statins have other beneficial properties besides their cholesterol lowering effect]

Eriksson M.

Lakartidningen. 1998 Aug 26;95(35):3670-2. Review. Swedish. PMID: 9748780 [PubMed - indexed for MEDLINE]Related articles

17.

Beneficial effects of statins in coronary artery disease--beyond lowering cholesterol.

Sotiriou CG, Cheng JW.

Ann Pharmacother. 2000 Dec;34(12):1432-9. Review.PMID: 11144702 [PubMed - indexed for MEDLINE]Related articles

18.

Biosynthesis and biotechnological production of statins by filamentous fungi and application of these cholesterol-lowering drugs.

Manzoni M, Rollini M.

Appl Microbiol Biotechnol. 2002 Apr;58(5):555-64. Epub 2002 Feb 14. Review.PMID: 11956737 [PubMed - indexed for MEDLINE]Related articles

19.

Hydrophobic but not hydrophilic statins enhance phagocytosis and decrease apoptosis of human peripheral blood cells in vitro.

Salman H, Bergman M, Djaldetti M, Bessler H.

Biomed Pharmacother. 2008 Jan;62(1):41-5. Epub 2007 Aug 9.PMID: 17768028 [PubMed - indexed for MEDLINE]Related articles

20.

Effects of statins on microglia.

Lindberg C, Crisby M, Winblad B, Schultzberg M.

J Neurosci Res. 2005 Oct 1;82(1):10-9.PMID: 16118799 [PubMed - indexed for MEDLINE]Related articles

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Find related data

Recent activity

Write to the Help Desk